Background and aim: In recent years, a few of the antibiotic-resistant bacteria, known as ESKAPE pathogens, have been found responsible for serious infections. We investigated the risk factors, and impact of ESKAPE pathogens on course of blood stream infections (BSIs) in cancer patients in comparison to coagulase negative Staphylococci (CoNS). Patients and methods: The data of patients with ESKAPE positive blood cultures at National Cancer Institute, Cairo University were analyzed. Identification and antimicrobial susceptibility of isolates were done using Microscan Walk Away 96. Results: In a 6 month period, ESKAPE pathogens were isolated from non-duplicate blood cultures in 81 episodes of 72 cases of pediatric cancer patients, while CoNS were isolated from 135 blood cultures of 116 patients. The ESKAPE pathogens isolated were Enterobacter spp., methicillinresistant Staphylococcus aureus (MRSA), Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterococci in 12%, 23%, 37%, 10%, 9%, and 9% of episodes, respectively. Health-care acquired infections constituted 75% of ESKAPE infections. Duration of episodes and overall mortality were significantly higher in ESKAPE BSIs when compared to CoNS (14.5 ± 7.6 versus 09.9 ± 6.9), and (26% versus 4%); respectively, p value <0.001. Conclusions: ESKAPE pathogens were significantly associated with higher rates of morbidity and mortality indicating the need for improving the means of prevention of these types of infections within health care premises. Microbiology laboratories have a role in defining more dangerous infections and rapid diagnostics are required in the era of resistance.
Introduction
Infections are still considered major causes of morbidity and mortality in cancer patients [1] . Pediatric oncology patients with fever, even when not neutropenic, are known to be at an increased risk of bloodstream infections (BSI) [2] . In the era of increased resistance, better understanding of infectious agents threatening patients with hematological malignancies and optimizing supportive care against these agents with efforts to prevent infections constitute life saving strategies. Gram positive organisms, mainly Coagulase negative Staphylococci (CoNS) constitute common causes of BSI in pediatric cancer patients [3] , especially with the increased use of central lines in this population of patients.
In recent years, the Infectious Diseases Society of America has highlighted a fraction of antibiotic-resistant bacteria (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp.) -acronymically dubbed 'the ESKAPE pathogens' -capable of 'escaping' the biocidal action of antibiotics and mutually representing new paradigms in pathogenesis, transmission and resistance [4] . The ESKAPE pathogens are responsible for a substantial percentage of nosocomial infections in the modern hospital and represent the vast majority of isolates whose resistance to antimicrobial agents presents serious therapeutic dilemmas for physicians [5] . Therefore, we attempted in this study to investigate the risk factors associated with blood stream infections caused by ESKAPE pathogens and their impact on the course of infectious episode, as regards duration of episode, and outcome in comparison to the more commonly isolated CoNS.
Patients and methods
This is a Microbiology laboratory based retrospective study, analysing the surveillance results of blood stream infections in collaboration with the Pediatric Oncology department at National Cancer Institute, Cairo University. National Cancer Institute is a tertiary care cancer center. Health care associated infection is an infection acquired within 72 h of patient hospitalization and patient was not in incubation period of infection. Feverish patients are investigated by blood culture testing prior to receiving empirical antibiotic therapy. Fever and neutropenia are defined according to the IDSA guidelines [6] . The data of patients with non-duplicate ESKAPE and CoNS positive blood cultures were collected from June to December 2012 including their age, diagnosis, disease status, hospitalization at day 1 of fever, co-morbidities, prior antibiotic intake in the previous month, last course of chemotherapy received and concomitant clinical documented infections. This study was approved by NCI Ethics Committee and an informed consent was obtained from parents of participants.
Microbiology
Two blood culture sets were drawn from each patient within the first day of fever from two separate veins. Bactec 9120Ò incubator was used. Identification of isolates was done using microscanÒ dried gram negative MIC/Combo and dried gram positive MIC/Combo panels Seimens Healthcare Diagnostics Ltd (Sir William Siemens Sq. Frimley, Cambeley, UK GU16 8QD). The panel of antibiotics used for Gram negative included amikacin, amoxicillin-clavulanate, ampicillinsulbactam, aztreonam, cefepime, cefoperazone, ceftazidime, cefuroxime, ciprofloxacin, gentamycin, imipenem, meropenem, norfloxacin, piperacillin, piperacillin-tazobactam, ticarcillinclavulanate. Antibiotics for Gram positive panels were trime thoprim-sulfamethoxazole, clindamycin, erythromycin, gentamycin, levofloxacin, linezolid, moxifloxacin, oxacillin, cefoxitin, synercid, tetracycline, and vancomycin. The susceptibility test results were interpreted according to the CLSI guidelines [7] . The MDR phenotype referred to non-susceptibility to at least one agent in three or more antimicrobial classes [8] .
Management and course of the episode
Local hospital guidelines necessitate hospitalization of febrile neutropenic patients to receive empirical therapy after risk assessment. The primary lines of empirical regimen during this period were either rocephin/amikacin (CRO/AK), or tazobactam/amikacin (TZP/AK); with meropenem/amikacin (MEM/ AK) as the secondary line. Patients received an empirical antifungal and an antiviral (zovirax) if fever persisted; and antibiotics continued until patients became afebrile and ANC exceeded 0.5 Â 10 9 L. Episodes were considered controlled when fever resolved within 5-7 days. Persistent fever for more than 7 days marked a prolonged episode. Mortality was recorded within one month of the beginning of an episode.
Statistical methods
Data were analyzed using IBM SPSS advanced statistics version 22 (SPSS Inc., Chicago, IL). Numerical data were expressed as mean and standard deviation. Qualitative data were expressed as frequency and percentage. Chi-square test was used to examine the relation between qualitative variables. For not normally distributed quantitative data, comparison between two groups was done using Mann-Whitney test (non-parametric t-test). The end points of the study were the duration of the episode and outcome of infection. All tests were two-tailed. A p-value <0.05 was considered significant.
Results
In a period of 6 months, ESKAPE pathogens were isolated from non-duplicate blood cultures n 81 episodes of 72 cases of pediatric cancer patients receiving their chemotherapy in the in-patient sector of Pediatric Oncology department of NCI, Cairo University. In the same period, CoNS were isolated from 135 blood cultures in 116 patients. The frequency of ESKAPE pathogens in relation to the total episodes of blood stream infections in febrile neutropenic pediatric cases in a period of 6 months were 81/336 (24%), while the relative frequency of CoNS were 135/336 (40%). The epidemiological features of the cases included in the study and different risk factors (health care associated infections, co-morbidities, prior febrile episode, chemotherapy either standard or intensified, clinically documented infections as mucositis, diarrhea, central venous line infection and respiratory tract infection, are illustrated in Table 1 . The difference in peripheral blood counts, absolute neutrophilic count, monocyte and platelet counts, together with duration of neutropenia are illustrated in Table 2 .
Microbiology
The ESKAPE pathogens isolated were Enterobacter spp., methicillin-resistant Staphylococcus aureus (MRSA), Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterococci in 10 (12%), 19 (23%), 30 (37%), 8 (10%), 7 (9%), and 7 (9%) episodes, respectively. The results of antibiotic susceptibility testing of ESKAPE pathogens revealed that 60/81 (74%) were MDR and 21/81 (26%) were antibiotic sensitive, while CoNS revealed that 56/135 (41.5%) were MDR and 79/135 (58.5%) were sensitive, p value <0.001.
Management and course of BSI
Comparison between management as regards primary line of therapy, shift of primary line to the secondary one, addition of vancomycin, and an antifungal given is provided in Table 3 . The course of the episodes, mainly duration and outcome within 2 weeks of first day of fever was recorded and the difference between ESKAPE and CoNS infections is listed in Table 3 . Duration of episodes was significantly longer and mortality rates were markedly higher among the cases infected with ESKAPE pathogens. The relation of mortality with different types of pathogens within the ESKAPE blood stream infections is illustrated in Fig. 1 .
Discussion
In recent medical practice, progress in supportive care following cancer chemotherapy has been successful in improving the outcome of patients with hematological malignancies. Yet, despite these advances, infections remain a major cause of morbidity, increase in healthcare costs and higher probability of disease relapse as a result of delay in chemotherapy [9] . Therefore, closer understanding of infections occurring in this population of patients may lead to better supportive care and subsequently attain higher outcome rates. It is essential to focus on patients with more risky infections, especially in the era of increasing antimicrobial resistance in a trial to modify local guidelines accordingly and set protocols for prevention [10, 11] . Thus, we attempted to investigate the impact of ESKAPE pathogens on the course of infectious episodes in comparison to CoNS that are more commonly isolated from blood cultures of pediatric patients with cancer at our institution [3] .
In the present study, the ESKAPE pathogens were significantly associated with infections with longer duration of episodes and higher mortality rates when compared to CoNS BSIs, with a p-value of <0.001. Within the ESKAPE pathogens, Pseudomonas aeruginosa and Klebsiella pneumoniae (Kp) were the most risky, with a mortality rate of 43% (3/7) and 30% (9/30), respectively. In a multicenter retrospective cohort study conducted in 3 large Italian teaching hospitals, the overall-30-day mortality rate for BSIs caused by carbapenem resistant Kp was 42% [12] . A similar study reported that persistence of bacteremia (25% vs. 9.7%), septic metastasis (8% vs. 4%) and early case-fatality rate (23% vs. 11%) were more frequent in patients with ESKAPE bacteremia than in patients with other etiologies (p < 0.05) [13] . In a recent study, comorbidities were independently associated with ESKAPE pathogens, with an overall fatality rate of 34% in the resistant ESKAPE bacteremic episodes and 22% in other bacterial causes; with a p-value of 0.06 [14] . In the latter study, sepsis persistence was more frequent in ESKAPE bacteremic episodes than in bacteremia due to other etiologies (25% versus 9.7%, p-value 0.001) [14] . Thus, it was concluded that bacteremia due to ESKAPE pathogens is an emerging problem in cancer patients especially among those with comorbidities receiving prior antibiotic treatment.
In the current study, ESKAPE pathogens were significantly associated with health care acquisition, p = 0.041. They were also, significantly more encountered in cases with clinically documented infections, p = <0.001, especially mucositis, central line, and respiratory tract infections, p = <0.001, 0.032, and 0.003; respectively. Similarly, prior hospitalization was significantly associated with ESKAPE infections [15] . Other risk factors that could predict ESKAPE pathogens, as prior febrile episodes, type of leukemia, intensified chemotherapy, and co-morbidities, did not differ in ESKAPE pathogens compared to CoNS. In another study, factors independently associated with ESKAPE bacteremia were prior transplantation, septic shock, and prior antibiotic therapy. Patients with ESKAPE BSIs received inappropriate empirical antibiotic therapy more often than the others (41% vs. 21.6%; p = 0.01), and showed a higher overall case-fatality rate (30 days) (35.2% vs. 14.4%; p = 0.001) [14] .
Although reduced neutrophil, monocyte, and platelet counts on day 1 in the present study did not show any difference between different causes of BSI, yet, peripheral blood counts on day 7 and duration of neutropenia were significantly less with longer duration of neutropenia in the infections caused by the ESKAPE pathogens. In a previous study conducted in the same institution, reduced ANC on day 1 was not associated with resistant bacterial infections, whereas, monocytic and platelet counts and prolonged duration of neutropenia were significantly associated with MDROs [16] .
Febrile neutropenic patients with cancer are a heterogeneous population of patients with high risk to develop infections caused by a wide array of pathogens ranging from skin flora up to highly virulent bacteria [17, 18] . The findings of the current study clarified the vast difference in the course of blood stream infections resulting from the ESKAPE pathogens when compared to the opportunistic CoNS. The antimicrobial resistant ESKAPE pathogens were significantly associated with higher rates of morbidity and mortality. Improving the understanding of the virulence attributed to different pathogens implicated in infections in cancer patients must be accompanied by better control measures for a better supportive care aiming at lower rates of infections caused by fatal pathogens in order to reduce morbidity and mortality. A systematic approach to surveillance, infection prevention, antimicrobial stewardship and clinical guidelines ensure best practice for infection control and management improving patient outcomes and reduce the spread of antimicrobial resistance. Microbiology laboratories in modern medicine have a role in defining more dangerous infections & have to help in more rapid diagnosis by introducing recent diagnostics that is urgently required in the era of resistance to reduce the 
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